BROOKE ELLINGER: Open Payments
NPI 1275144099 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 12 payments from 5 companies in 2025. Trend: 2023 $393 · 2024 $285 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $108 |
| Sage Therapeutics, LLC | 3 | $55 |
| MILLICENT US INC | 2 | $38 |
| Amgen Inc. | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: Veozah, ZURZUVAE, FEMLYV, EVENITY, Qelbree.
Industry payments across MD — which companies pay providers there.
